• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

是什么原因导致欧洲地区胃癌患者的长期生存率存在差异?

What reasons lie behind long-term survival differences for gastric cancer within Europe?

机构信息

Digestive Cancer Registry (INSERM U866), Dijon, France.

出版信息

Eur J Cancer. 2010 Apr;46(6):1086-92. doi: 10.1016/j.ejca.2010.01.019. Epub 2010 Feb 15.

DOI:10.1016/j.ejca.2010.01.019
PMID:20163952
Abstract

BACKGROUND

Wide geographic variations in survival for gastric cancer in Europe have been reported. The aim of this study was to analyse the effect of stage at diagnosis, treatment and cancer characteristics on long-term survival for gastric cancer in populations covered by cancer registries.

METHODS

We analysed survival in 4620 cases of gastric cancer from 17 European population-based cancer registries from 8 countries. Univariate and multivariate regression of relative survival were performed.

RESULTS

Five-year relative survival varied between 10.6% and 24.0%, while 10-year survival ranged from 7.7% to 23.0%. After adjustment for age and sex, the regional excess hazard ratio (EHR) of death was significantly higher in Ragusa, Granada, Yorkshire, Slovakia, Slovenia and Poland than in France, Northern Italy, The Netherlands and the Basque Country. After further adjustment for surgical resection versus no resection (a proxy of stage), the EHR of death remained significantly higher only in Granada and Yorkshire than in the reference country (France). After adjustment for stage, the EHR was significantly higher only in Yorkshire (EHR: 1.51; 95% confidence interval (CI): 1.29-1.77). The EHR in this area was limited to the first year following diagnosis.

CONCLUSION

Differences across Europe in gastric cancer survival depend to a large extent on differences in stage at diagnosis. However they do not explain all variations. Quality of management and treatment can explain some differences.

摘要

背景

在欧洲,胃癌的生存率存在广泛的地域差异。本研究旨在分析诊断时的分期、治疗和癌症特征对癌症登记覆盖人群中胃癌长期生存率的影响。

方法

我们分析了来自 8 个国家的 17 个欧洲基于人群的癌症登记处的 4620 例胃癌病例的生存情况。进行了单变量和多变量相对生存率回归分析。

结果

5 年相对生存率在 10.6%至 24.0%之间,10 年生存率在 7.7%至 23.0%之间。在调整年龄和性别后,与法国相比,拉古萨、格拉纳达、约克郡、斯洛伐克、斯洛文尼亚和波兰的区域死亡超额危险比(EHR)显著更高。在进一步调整手术切除与未切除(分期的替代指标)后,死亡的 EHR 仅在格拉纳达和约克郡仍显著高于参考国家(法国)。在调整分期后,EHR 仅在约克郡显著更高(EHR:1.51;95%置信区间(CI):1.29-1.77)。该地区的 EHR 仅在诊断后第一年显著。

结论

欧洲各国之间在胃癌生存率方面的差异在很大程度上取决于诊断时的分期差异。然而,它们并不能解释所有的差异。管理和治疗质量可以解释一些差异。

相似文献

1
What reasons lie behind long-term survival differences for gastric cancer within Europe?是什么原因导致欧洲地区胃癌患者的长期生存率存在差异?
Eur J Cancer. 2010 Apr;46(6):1086-92. doi: 10.1016/j.ejca.2010.01.019. Epub 2010 Feb 15.
2
Survival for ethmoid sinus adenocarcinoma in European populations.欧洲人群筛窦腺癌的生存率。
Acta Oncol. 2009;48(7):992-8. doi: 10.1080/02841860902874755.
3
Operative mortality after gastric cancer resection and long-term survival differences across Europe.欧洲胃癌切除术术后死亡率与长期生存差异。
Br J Surg. 2010 Feb;97(2):235-9. doi: 10.1002/bjs.6865.
4
Survival for cancer patients in Europe.欧洲癌症患者的生存率。
Ann Ist Super Sanita. 2009;45(3):315-24.
5
Influence of stage at diagnosis on survival differences for rectal cancer in three European populations.诊断分期对三个欧洲人群中直肠癌生存差异的影响。
Br J Cancer. 1999 Oct;81(3):463-8. doi: 10.1038/sj.bjc.6690716.
6
Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?IV期胃癌切除术后的结果;在特定患者亚组中是否观察到更好的结局?
J Surg Oncol. 2007 Feb 1;95(2):118-22. doi: 10.1002/jso.20328.
7
Gender differences in stomach cancer survival in Osaka, Japan: analyses using relative survival model.日本大阪胃癌生存率的性别差异:使用相对生存模型的分析
Jpn J Clin Oncol. 2009 Oct;39(10):690-4. doi: 10.1093/jjco/hyp084. Epub 2009 Aug 17.
8
Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control.荷兰可切除性非贲门胃癌患者生存率的提高:手术培训和质量控制的重要性。
Eur J Surg Oncol. 2009 Jul;35(7):715-20. doi: 10.1016/j.ejso.2008.12.008. Epub 2009 Jan 13.
9
Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study.睾丸癌的十年生存率和复发风险:一项欧洲癌症和营养前瞻性调查(EUROCARE)高分辨率研究
Eur J Cancer. 2007 Feb;43(3):585-92. doi: 10.1016/j.ejca.2006.11.006. Epub 2007 Jan 11.
10
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.欧洲癌症患者护理与评估研究(EUROCARE)-4。1995 - 1999年确诊的癌症患者生存率。结果与评论。
Eur J Cancer. 2009 Apr;45(6):931-91. doi: 10.1016/j.ejca.2008.11.018. Epub 2009 Jan 24.

引用本文的文献

1
Effect of Age at Diagnosis on the Prognosis of Gastric Cancer Patients: A Population-Based Study in Georgia.确诊年龄对胃癌患者预后的影响:一项基于佐治亚州人群的研究
Cureus. 2024 Jun 11;16(6):e62154. doi: 10.7759/cureus.62154. eCollection 2024 Jun.
2
Multidisciplinary team consultation for resectable Gastric Cancer: A propensity score matching analysis.可切除胃癌的多学科团队会诊:一项倾向评分匹配分析。
J Cancer. 2021 Jan 30;12(7):1907-1914. doi: 10.7150/jca.53365. eCollection 2021.
3
Investigating the association between rs6983267 polymorphism and susceptibility to gastrointestinal cancers in Iranian population.
研究 rs6983267 多态性与伊朗人群胃肠道癌症易感性的关系。
Mol Biol Rep. 2021 Mar;48(3):2273-2284. doi: 10.1007/s11033-021-06249-5. Epub 2021 Mar 13.
4
Abdominal Drainage and Amylase Measurement for Detection of Leakage After Gastrectomy for Gastric Cancer.胃癌胃切除术后引流和淀粉酶测量检测漏的价值。
J Gastrointest Surg. 2018 Jul;22(7):1163-1170. doi: 10.1007/s11605-018-3789-7. Epub 2018 May 7.
5
Knockdown of KRT17 by siRNA induces antitumoral effects on gastric cancer cells.siRNA 介导的 KRT17 敲低可诱导胃癌细胞产生抗肿瘤作用。
Gastric Cancer. 2017 Nov;20(6):948-959. doi: 10.1007/s10120-017-0712-y. Epub 2017 Mar 15.
6
Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients.Tbet+效应T细胞和CD20+B细胞的肿瘤浸润与胃癌患者的生存率相关。
Oncoimmunology. 2015 Jun 3;5(2):e1054598. doi: 10.1080/2162402X.2015.1054598. eCollection 2016 Feb.
7
Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital.胃癌患者的手术治疗结果:一家中国大型医院的11年经验。
Med Oncol. 2014 Sep;31(9):150. doi: 10.1007/s12032-014-0150-1. Epub 2014 Aug 12.
8
Trends in the management of gastric cancer over a 32-year period: a French population-based study.32年间胃癌管理的趋势:一项基于法国人群的研究。
Gastric Cancer. 2015 Jan;18(1):129-37. doi: 10.1007/s10120-014-0342-6. Epub 2014 Feb 1.
9
Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?澳大利亚、加拿大、丹麦、挪威、瑞典和英国(国际癌症基准合作组织)之间的癌症认知和信念差异:它们是否导致癌症生存率的差异?
Br J Cancer. 2013 Feb 5;108(2):292-300. doi: 10.1038/bjc.2012.542. Epub 2013 Jan 31.
10
Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer.胃癌患者手术前后血清 VEGF 和 VEGF-C 值。
Clin Transl Oncol. 2013 Apr;15(4):265-70. doi: 10.1007/s12094-012-0908-x. Epub 2012 Jul 24.